检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]河北医科大学第四医院生物治疗科
出 处:《药品评价》2012年第18期26-34,共9页Drug Evaluation
摘 要:目的应用胰腺癌小鼠模型来研究吉西他滨是否可以提高树突状细胞瘤苗接种的疗效。方法 C57B L/6小鼠成功负载经紫外线辐射后的PanO2癌细胞后,从小鼠体内获得骨髓源性DCs然后经皮下给药。预防性接种的小鼠在PanO2癌细胞形成肿瘤威胁前接种瘤苗,每隔一周接种3次,治疗性接种于肿瘤形成可触及结节时开始。吉西他滨经腹腔给药,每周两次。结果预防性DC瘤苗接种可全面阻止皮下及原位肿瘤的发展并且可诱导肿瘤抗原特异性CTLs及免疫记忆。对于已形成皮下肿瘤的模型,治疗性DC瘤苗接种与吉西他滨同样有效(肿瘤威胁形成后58天生存率分别为14%和17%,对照组0%)。以上两种方法联合可显著提高带瘤小鼠的生存率(肿瘤威胁形成后58天生存率为50%)。树突状细胞瘤苗接种也可以预防静脉注射PanO2细胞后肺转移导致的死亡。结论:树突状细胞免疫治疗不仅可以成功地与吉西他滨联合治疗晚期胰腺癌,还能够有效地预防无瘤患者的肿瘤局部复发及转移。Objective To study that if the therapeutic effect of DC vaccine inoculation could be improved by gemcitabine in mice model of pancreatic cancer. Bone marrow-derived DC cells acquired from C57BL/6 mice that load PanO2 cancer cells which already were accepted ultraviolet radiation were administered subcutaneously. Mice of protective inoculation were inoculated before PanO2 cancer cells formed neoplasm,3 times every two weeks. While therapeutic inoculation was performed after the tumor mass could be touch. Mice were administered with gemcitabine intraperitoneal,twice a week. Protective inoculation of DC vaccine could prohibit the tumor progression subcutaneous and in situ,and induce CTLs with tumor specificity and immunologic memory. As for mice with subcutaneous tumor mass,both of therapeutic inoculation and gemcitabine were effective (58 days survival rates after tumor formed were 14% and 17% respectively, while control group was 0%).The combination of two methods above could notably improve the survival rate of mice with tumor (58 days survival rate after tumor formed was 50%). DC vaccine also prevented death caused by lung metastasis after injected PanO2 cancer cells intravenously. Conclusion Immunotherapy with DC vaccine could not only treat advanced pancreatic cancer combining with gemcitabine but also effectively protect ones without tumor mass from local recurrence and metastasis.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222